PharVision Advisers’s Arrive AI Inc ARAI Stock Holding History

PharVision Advisers’s Portfolio ARAI Stock Details ARAI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-16,511	Closed	-$60.1K	–	1061
2025 Q3	$60.1K	Buy	+16,511	New	+$110K	0.03%	645

Other funds holding ARAI

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

LWM

LJI Wealth Management Indianapolis, Indiana $714M AUM 21.51% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

PharVision Advisers's ARAI Position: Q4 2025 in Review

PharVision Advisers sold out of Arrive AI Inc (ARAI) in Q4 2025, closing a stake of 16,511 shares — an estimated $60.1K sold.

PharVision Advisers first reported a position in ARAI in Q3 2025 and held it in 1 quarter. The position peaked at $60.1K in Q3 2025. 34 funds tracked by Wall St. Rank hold ARAI as of Q4 2025.

PharVision Advisers reported no remaining Arrive AI Inc position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 16,511 Arrive AI Inc shares in Q4 2025, an estimated $60.1K.
PharVision Advisers first reported a position in Arrive AI Inc in Q3 2025 and held it in 1 quarter.
PharVision Advisers's Arrive AI Inc position peaked at $60.1K in Q3 2025.
34 funds tracked by Wall St. Rank held Arrive AI Inc as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.